Stock Fundamentals

Company Information

Company Name
Pmv Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US69353Y1038
CIK: 0001699382
CUSIP: 69353Y103
Currency: USD
Full Time Employees: 54
Phone: 609 642 6670
Fiscal Year End: December
IPO Date: Sep 25, 2020
Description:

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.

Address:

400 Alexander Park Drive, Princeton, NJ, United States, 08540

Directors & Officers

Name Title Year Born
Dr. David H. Mack Ph.D. Co-Founder, CEO, President & Director 1962
Dr. Arnold J. Levine Ph.D. Co-Founder, Independent Director & Member of Scientific Advisory Board 1940
Mr. Robert Ticktin J.D. General Counsel, COO & Company Secretary 1962
Dr. Deepika Jalota Pharm.D. Chief Development Officer 1977
Mr. Michael Carulli Chief Financial Officer 1974
Mr. Tim Smith M.B.A. Senior VP and Head of Corporate Development & Investor Relations NA
Ms. Crystal Zuckerman Vice President of Human Resources NA
Dr. Binh Vu Ph.D. Senior Vice President of Drug Discovery & CMC NA
Dr. Marc Fellous M.D. Senior VP and Head of Clinical Development & Medical Affairs NA
Ms. Laura De Leon VP & Head of Clinical Development Operations NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Oct 23, 2025 Orbimed Advisors Llc N/A Sale 1.00M $1.52 $1.52M
Sep 10, 2025 Orbimed Advisors Llc N/A Sale 500.00K $1.80 $900.00K
Jul 01, 2025 David Henry Mack N/A Sale 58.41K $1.06 $61.92K
Jul 01, 2025 Deepika Jalota N/A Sale 33.07K $1.06 $35.05K
Jul 01, 2025 Robert Ticktin N/A Sale 23.15K $1.06 $24.54K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BML Capital Management LLC 5.32M Mar 31, 2026 9.98% $4.24 0.53%
TANG CAPITAL MANAGEMENT LLC 4.25M Mar 31, 2026 7.96% $0.27 -14.07%
Sio Capital Management, LLC 3.08M Mar 31, 2026 5.77% $0.55 16.69%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 2.87M Mar 31, 2026 5.39% $0.09 -7.03%
Euclidean Capital LLC 2.63M Mar 31, 2026 4.93% $0.83 0.00%
Eversept Partners, LP 2.35M Mar 31, 2026 4.40% $0.15 0.00%
Acadian Asset Management LLC 2.22M Mar 31, 2026 4.15% $0.00 0.00%
Vanguard Group Inc 2.17M Dec 31, 2025 4.07% $0.00 0.34%
Vanguard Capital Management, LLC 1.97M Mar 31, 2026 3.70% $0.00 0.00%
Two Sigma Investments LLC 1.88M Mar 31, 2026 3.53% $0.00 166.91%
Adage Capital Partners Gp LLC 1.86M Mar 31, 2026 3.49% $0.00 0.00%
BlackRock Inc 874.37K Mar 31, 2026 1.64% $0.00 -20.14%
Two Sigma Advisers, LLC 874.10K Dec 31, 2025 1.64% $0.00 109.16%
Morgan Stanley - Brokerage Accounts 864.31K Mar 31, 2026 1.62% $0.00 774.15%
Stonepine Capital Management Llc 708.10K Mar 31, 2026 1.33% $0.35 -38.47%
Geode Capital Management, LLC 495.92K Mar 31, 2026 0.93% $0.00 11.16%
Aldebaran Capital LLC 473.36K Mar 31, 2026 0.89% $0.45 -0.97%
Marshall Wace Asset Management Ltd 434.09K Mar 31, 2026 0.81% $0.00 -6.66%
Bridgeway Capital Management, LLC 428.85K Mar 31, 2026 0.80% $0.01 0.00%
Assenagon Asset Management SA 360.79K Mar 31, 2026 0.68% $0.00 156.85%

Shares Statistics

Shares Outstanding: 53.33M
Shares Float: 43.14M
% Insiders: 334.80%
% Institutions: 6,774.90%
Short % Float: 5.65%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 1.49M 2.79% ▲ 0.00% Apr 30, 2026
2 Meridian Small Cap Growth Legacy 1.08M 2.02% ▼ 13.42% Mar 31, 2026
3 ArrowMark Small Cap Gro 1.08M 2.02% ▼ 13.42% Mar 31, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 454.06K 0.85% ▲ 0.00% Apr 30, 2026
5 Bridgeway Ultra-Small Company 331.45K 0.62% ▲ 0.00% Mar 31, 2026
6 Fidelity Extended Market Index 232.87K 0.44% ▼ 0.36% Apr 30, 2026
7 iShares Micro-Cap ETF 113.55K 0.21% ▲ 0.00% May 29, 2026
8 Extended Equity Market Fund B 100.09K 0.19% ▲ 0.00% Dec 31, 2025
9 Extended Equity Market Fund E 100.09K 0.19% ▲ 0.00% Dec 31, 2025
10 Blackrock Extended Mkt Fund CF 100.09K 0.19% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $-27.12M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $66.13M
EBITDA: $-83.53M
Book Value: $1.65
Earnings/Share: $-1.48
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -39.14%
ROE (TTM): -63.16%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 10.09x 0.00x 0.10x N/A -0.01x
2024-12-31 12.22x 0.00x 0.08x N/A 0.00x
2023-12-31 14.78x 0.00x 0.10x N/A -0.01x
2022-12-31 22.80x 0.00x 0.09x -19.12x -0.01x
2021-12-31 24.66x 0.00x 0.07x -75.02x -0.01x
2020-12-31 56.90x 0.00x 0.02x -42.30x 0.00x
2019-12-31 22.57x 0.00x 1.68x -20.60x 0.00x
2018-12-31 26.75x 0.00x 1.73x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PMVP.US!